While these studies were not eligible for inclusion in our systematic review, they provide hypothesis-generating evidence supporting further investigation of SGLT2 inhibitors in HF populations using standardized, multidomain cognitive assessments and longer follow-up. This evidence concerns the gene SLC5A2 and hydrops fetalis.